Notification

Get Free Job Alerts in your Email - Subscribe now

Advanced Centre for Treatment, Research & Education in Cancer Notification 2018: Jr. Assistant & Attendant

Applications are invited for filling up the following vacancies :

Organisation Posts Qualification Salary
Jr. Assistant 01 Post Graduate degree with Computer course in office software Rs.17,000/- per month
Attendant 01 Post 12th Std. Passed Rs.10,000/- per month

Duration : Six months and extendable.

Eligible Candidates may attend the walk in interview along with Bio-data,Original Certificate, Photo,Pan Card etc. with Xerox copies on 24.09.2018 at 10.30 a.m .

Reporting Time : 10.00 a.m to 11.00 a.m

Venue: Room No.205, 2nd Floor, Centre for Cancer Epidemiology, Advanced  Centre for Treatment, Research & Education in Cancer, Sector 22, Kharghar,  Navi Mumbai – 410210″.

The Advanced Centre for Treatment, Research and Education in Cancer  (ACTREC) is the state-of-the-art R&D satellite of the Tata Memorial Centre  (TMC), which also includes under its umbrella the Tata Memorial Hospital  (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer.  TMC is an autonomous grant-in-aid institution of the Department of Atomic  Energy (DAE), Government of India. It is registered under the Societies   Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing  Council is headed by the Chairman, Atomic Energy Commission,  Government of India.

ACTREC comprises of 2 arms – one for basic research and another for clinical  research. The basic research building was inaugurated in March 2002 at the  new site of ACTREC in Kharghar, Navi Mumbai. In August 2002, the Cancer  Research Institute (CRI) shifted in toto from its Parel campus in Mumbai to serve as the basic research arm of ACTREC. The clinical research arm of  ACTREC comprising of the Clinical Research Centre (CRC) became  functional from March 2005. ACTREC also has a 100-bed hospital fully equipped with state-of-the-art diagnostic and therapeutic facilities. Research  investigations at CRI currently focus on molecular mechanisms responsible  for causation of major human cancers relevant to India. It is envisaged that in the future, ACTREC will play a greater role in drug development and emerging therapies for treatment and prevention of cancer.

Date of interview: September 24, 2018

Reference Link : Original notification

Website : www.actrec.gov.in